Captor Therapeutics Spolka Akcyjna CTX.WA Stock
Captor Therapeutics Spolka Akcyjna Price Chart
Captor Therapeutics Spolka Akcyjna CTX.WA Financial and Trading Overview
| Captor Therapeutics Spolka Akcyjna stock price | 81 PLN |
| Previous Close | 160 PLN |
| Open | 157 PLN |
| Bid | 155.5 PLN x N/A |
| Ask | 159 PLN x N/A |
| Day's Range | 155 - 160 PLN |
| 52 Week Range | 102.5 - 188 PLN |
| Volume | 203 PLN |
| Avg. Volume | 1.63K PLN |
| Market Cap | 673.46M PLN |
| Beta (5Y Monthly) | 0.905109 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -15.2 PLN |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 216.25 PLN |
CTX.WA Valuation Measures
| Enterprise Value | 596.89M PLN |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 69.6807 |
| Price/Book (mrq) | 8.073876 |
| Enterprise Value/Revenue | 61.758 |
| Enterprise Value/EBITDA | -16.487 |
Trading Information
Captor Therapeutics Spolka Akcyjna Stock Price History
| Beta (5Y Monthly) | 0.905109 |
| 52-Week Change | 25.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 188 PLN |
| 52 Week Low | 102.5 PLN |
| 50-Day Moving Average | 160.96 PLN |
| 200-Day Moving Average | 161.39 PLN |
CTX.WA Share Statistics
| Avg. Volume (3 month) | 1.63K PLN |
| Avg. Daily Volume (10-Days) | 304 PLN |
| Shares Outstanding | 4.21M |
| Float | 2.09M |
| Short Ratio | N/A |
| % Held by Insiders | 45.32% |
| % Held by Institutions | 14.70% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -444.56% |
| Gross Margin | 76.84% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.73% |
| Return on Equity (ttm) | -39.32% |
Income Statement
| Revenue (ttm) | 9.67M PLN |
| Revenue Per Share (ttm) | 2.31 PLN |
| Quarterly Revenue Growth (yoy) | 48.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -36205000 PLN |
| Net Income Avi to Common (ttm) | -39148000 PLN |
| Diluted EPS (ttm) | -9.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 82.55M PLN |
| Total Cash Per Share (mrq) | 19.61 PLN |
| Total Debt (mrq) | 5.98M PLN |
| Total Debt/Equity (mrq) | 7.17 PLN |
| Current Ratio (mrq) | 5.714 |
| Book Value Per Share (mrq) | 19.817 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24794000 PLN |
| Levered Free Cash Flow (ttm) | -17180124 PLN |
Profile of Captor Therapeutics Spolka Akcyjna
| Country | Poland |
| State | N/A |
| City | Wroclaw |
| Address | ul. Dunska 11 |
| ZIP | 54-427 |
| Phone | 48 53 786 9089 |
| Website | https://www.captortherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 111 |
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.
Q&A For Captor Therapeutics Spolka Akcyjna Stock
What is a current CTX.WA stock price?
Captor Therapeutics Spolka Akcyjna CTX.WA stock price today per share is 81 PLN.
How to purchase Captor Therapeutics Spolka Akcyjna stock?
You can buy CTX.WA shares on the Warsaw exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Captor Therapeutics Spolka Akcyjna?
The stock symbol or ticker of Captor Therapeutics Spolka Akcyjna is CTX.WA.
Which industry does the Captor Therapeutics Spolka Akcyjna company belong to?
The Captor Therapeutics Spolka Akcyjna industry is Biotechnology.
How many shares does Captor Therapeutics Spolka Akcyjna have in circulation?
The max supply of Captor Therapeutics Spolka Akcyjna shares is 4.65M.
What is Captor Therapeutics Spolka Akcyjna Price to Earnings Ratio (PE Ratio)?
Captor Therapeutics Spolka Akcyjna PE Ratio is now.
What was Captor Therapeutics Spolka Akcyjna earnings per share over the trailing 12 months (TTM)?
Captor Therapeutics Spolka Akcyjna EPS is -15.2 PLN over the trailing 12 months.
Which sector does the Captor Therapeutics Spolka Akcyjna company belong to?
The Captor Therapeutics Spolka Akcyjna sector is Healthcare.